Vahid Fallah Omrani

Vahid Fallah Omrani

Auto-generated profile, based on publicly available information

Vahid Fallah Omrani

Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2017 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MGMazaher Gholipourmalekabadi
Mazaher Gholipourmalekabadi
MMMohammadmahdi Mobaraki
Mohammadmahdi Mobaraki
MGMaryam Ghaffari
Maryam Ghaffari
AZAmir Zarebkohan
Amir Zarebkohan
VOVahid Fallah Omrani
Vahid Fallah Omrani
Alexander Marcus SeifalianAlexander Marcus Seifalian
Alexander Marcus Seifalian
Drug delivery systems are effective and attractive methods which allow therapeutic substances to be introduced into the body more effectively and safe by having tunable delivery rate and release target site. Gold nanoparticles (AuNPs) have a myriad of favorable physical, chemical, optical, thermal and biological properties that make them highly suitable candidates as non-toxic carriers for drug and gene delivery. The surface modifications of AuNPs profoundly improve their circulation, minimize aggregation rates, enhance attachment to therapeutic molecules and target agents due to their nano range size which further increases their ability to cross cell membranes and reduce overall cytotoxicity. This comprehensive article reviews the applications of the AuNPs in drug delivery systems along with their corresponding surface modifications. The highlighting results obtained from the preclinical trial are promising and next five years have huge possibility move to the clinical setting.

1 May 2016 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
ARAli Rostami
Ali Rostami
MEMaryam Ebrahimi
Maryam Ebrahimi
SMSaeed Mehravar
Saeed Mehravar
VOVahid Fallah Omrani
Vahid Fallah Omrani
SFShirzad Fallahi
Shirzad Fallahi
HBHamed Behniafar
Hamed Behniafar

14 April 2015 in Infection
Verified
Journal Article
Closed access
PDF file
VOV. Fallah Omrani
V. Fallah Omrani
SFSh. Fallahi
Sh. Fallahi
ARAli Rostami
Ali Rostami
ASA. Siyadatpanah
A. Siyadatpanah
GBGh. Barzgarpour
Gh. Barzgarpour
ZJZ. Joneidi
Z. Joneidi

1 February 2014 in Parasitology International
Verified
Journal Article
Closed access
SFSh. Fallahi
Sh. Fallahi
BKBahram Kazemi
Bahram Kazemi
STS.J. Seyyed Tabaei
S.J. Seyyed Tabaei
MBMOJGAN BANDEHPOUR
MOJGAN BANDEHPOUR
ZLZ. Lasjerdi
Z. Lasjerdi
FEF. Ebrahimzadeh
F. Ebrahimzadeh

13 January 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ABAlireza Badirzadeh
Alireza Badirzadeh
MHMaryam Heidari-Kharaji
Maryam Heidari-Kharaji
VFVahid Fallah-Omrani
Vahid Fallah-Omrani
HDHossein Dabiri
Hossein Dabiri
AAAtefeh Araghi
Atefeh Araghi
ACAlireza Salimi Chirani
Alireza Salimi Chirani
Neglected parasitic diseases (NTDs) like cutaneous leishmaniasis (CL) have caused high mortality and morbidity rate in developing countries. This disease is considered as one of the six major tropical diseases, and has a great importance in HIV infected individuals as an opportunistic infection in those areas that both infections are endemic. This study evaluated the therapeutic effects of the Urtica dioica L (U. dioica) aqueous extract as an anti-leishmanial herbal drug in-vitro and in-vivo, and in addition to that, evaluated two vital immune system cytokines including gamma interferon (IFN-γ) and interleukin-4 (IL-4) plus nitric oxide (NO) and arginase activity against Leishmania major (L. major) infected mice. In-vitro anti-leishmanial activity of U. dioica aqueous extract was determined using MTT method and also Parasite Rescue Transformation Assay. Also, the footpad lesion size and parasite load in BALB/c mice infected with L. major were quantified for in-vivo assessment. Furthermore, for evaluating the immune responses, the levels of IFN-γ, IL-4, NO and arginase were measured in the BALB/c mice. These results indicated that U. dioica extract significantly reduced the L. major promastigotes viability. According to the in-vitro cytotoxicity assay of the extract on Leishmania parasites (CC50) and infected macrophages (EC50), the extract had no toxicity to the macrophages, however it efficiently killed the L. major amastigotes. In addition, the lesion size, parasite load, IL-4, and ARG were decreased in the treated infected mice, however IFN-γ and NO were significantly increased. This study established satisfactory results in Leishmania parasite clearing both in-vivo and in-vitro. Therefore, U. dioica extract can be considered as an effective and harmless herbal compound for killing the parasite without toxicity to the host macrophages. Furthermore, it also can treat the CL by switching the mouse immune response towards a cell-mediated response (Th1); hence, it may be identified as a perfect therapeutic herbal drug for CL treatment. Nowadays, neglected tropical diseases (NTDs) like leishmaniasis have increased the mortality and morbidity rate in developing countries, especially in tropical regions, and is considered as responsible for more than 20 million deaths per year. Although, cutaneous leishmaniasis (CL) is rapidly spreading in all over the world, but this disease controlling has remained insufficient because of low-cost treatment and the lack of an effective vaccine. Therefore, new treatment approaches for leishmaniasis are immediately required. Up to now, application of natural herbal products has been considered as one of the major effective ways in treating the protozoan parasitic infections like CL. In this study, we evaluated the therapeutic effects of the Urtica dioica L (U. dioica) aqueous extract as an anti-leishmanial herbal drug in-vitro and in-vivo, and also quantified the immune cytokines IFN-γ, IL-4 against CL caused by Leishmania major (L. major). The in-vitro activity of U. dioica aqueous extract on L. major was determined using MTT method and Parasite Rescue Transformation Assay. Moreover, the footpad lesion size was assessed and parasite load in the mice infected with L. major was quantified for in-vivo. In order to evaluate the immune responses, IFN-γ, IL-4, NO and arginase were measured in the Leishmania infected mice. Accordingly, U. dioica is one of the effective herbal plant in L. major parasite clearing without any harmful toxicity to the murine cells, and can strongly cure the zoonotic CL.

25 August 2018 in Amino Acids
Verified
Journal Article
Closed access
PDF file
MMMehrdad Moosazadeh Moghaddam
Mehrdad Moosazadeh Moghaddam
MEMohamad Eftekhary
Mohamad Eftekhary
SESoroor Erfanimanesh
Soroor Erfanimanesh
AHAli Hashemi
Ali Hashemi
VOVahid Fallah Omrani
Vahid Fallah Omrani
MGMazaher Gholipourmalekabadi
Mazaher Gholipourmalekabadi